Abbonarsi

Myocardial perfusion, function, and dyssynchrony in patients with heart failure: Baseline results from the single-photon emission computed tomography imaging ancillary study of the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) Trial - 13/08/11

Doi : 10.1016/j.ahj.2009.07.009 
Allen E. Atchley, MD a, Dalane W. Kitzman, MD b, David J. Whellan, MD c, Ami E. Iskandrian, MD d, Stephen J. Ellis, PhD a, Robert A. Pagnanelli, NCT a, Andrew Kao, MD e, Khaled Abdul-Nour, MD f, Christopher M. O'Connor, MD a, Greg Ewald, MD g, William E. Kraus, MD a, Salvador Borges-Neto, MD a,

for the HF-ACTION Investigatorsh

a Duke University Medical Center, Durham, NC 
b Wake Forest University School of Medicine, Winston-Salem, NC 
c Jefferson Medical College, Philadelphia, PA 
d University of Alabama at Birmingham, Birmingham, AL 
e Mid-America Heart Institute, Kansas City, MO 
f Henry Ford Hospital, Detroit, MI 
g Washington University, St. Louis, MO 
h A complete list of the HF-ACTION investigators is available as an appendix in the introduction of this supplement. 

Reprint requests: Salvador Borges-Neto, MD, Department of Medicine and Radiology, Duke University Medical Center, Durham, NC 27710.

Riassunto

Background

There are currently limited data on the relationships between resting perfusion abnormalities, left ventricular ejection fraction (LVEF), New York Heart Association (NYHA) functional class, and exercise capacity as defined by peak V̇o2 and 6-minute walk test in patients with heart failure (HF) and reduced LVEF. Furthermore, the association between resting perfusion abnormalities and left ventricular dyssynchrony is currently unknown. This article addresses the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) gated SPECT imaging (gSPECT) substudy baseline results.

Methods

HF-ACTION was a multicenter, randomized controlled trial of aerobic exercise training versus usual care in 2,331 stable patients with LVEF of ≤35% and NYHA class II to IV HF symptoms treated with optimal medical therapy. Subjects enrolled in the HF-ACTION substudy underwent resting Tc-99m tetrofosmin gSPECT at baseline (n = 240). Images were evaluated for extent and severity of perfusion abnormalities using a 17-segment and a 5-degree gradation severity score (summed rest score [SRS]). Left ventricular function and dyssynchrony were assessed using validated available commercial software.

Results

The average age of patients enrolled was 59, 69% were male, 63% were white, and 33% were African American. Of the 240 participants, 129 (54%) were ischemic and 111 (46%) were nonischemic in etiology. The median LVEF by gSPECT for the entire cohort was 26%. Among the nuclear variables, there was a modest correlation between LVEF and SRS (r = −0.31, P < .0001) and there were stronger correlations between phase SD and SRS (r = 0.66, P < .0001) as well as phase SD and LVEF (r = −0.50, P < .0001). Patients with NYHA class III symptoms had more severe and significant degrees of dyssynchrony (median phase SD 54°) than those with NYHA class II symptoms (median phase SD 39°, P = .001). Patients with an ischemic etiology had a higher SRS (P < .0001) and significantly more dyssynchrony (P < .0001) than those who were nonischemic. However, there was no difference in LVEF or objective measures of exercise capacity between these groups. With respect to peak V̇o2, there was a weak correlation with LVEF (r = 0.18, P = .006) and no correlation with SRS (r = −0.04, P = 0.59) or with dyssynchrony (r = −0.13, P = .09). A weak but statistically significant correlation between SRS and 6-minute walk was observed (r = −0.15, P = .047).

Conclusions

Gated SPECT imaging can provide important information in patients with HF due to severe LV dysfunction including quantitative measures of global systolic function, perfusion, and dyssynchrony. These measurements are modestly but significantly related to symptom severity and objective measures of exercise capacity.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 ClinicalTrials.gov Identifier: NCT00047437.
 Funding was received from National Institutes of Health (grants 5U01HL063747, 5U01HL068973, 5U01HL066501, 5U01HL066482, 5U01HL064250, 5U01HL066494, 5U01HL064257, 5U01HL066497, 5U01HL068980, 5U01HL064265, 5U01HL066491, 5U01HL064264, 5U01HL066461, R37AG18915, and P60AG10484).


© 2009  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 158 - N° 4S

P. S53-S63 - ottobre 2009 Ritorno al numero
Articolo precedente Articolo precedente
  • Relationship of Doppler-Echocardiographic left ventricular diastolic function to exercise performance in systolic heart failure: The HF-ACTION study
  • Julius M. Gardin, Eric S. Leifer, Jerome L. Fleg, David Whellan, Peter Kokkinos, Marie-Helene LeBlanc, Eugene Wolfel, Dalane W. Kitzman, for the HF-ACTION Investigators
| Articolo seguente Articolo seguente
  • Outcomes, health policy, and managed care: Relationships between patient-reported outcome measures and clinical measures in outpatients with heart failure
  • Kathryn E. Flynn, Li Lin, Stephen J. Ellis, Stuart D. Russell, John A. Spertus, David J. Whellan, Ileana L. Piña, Lawrence J. Fine, Kevin A. Schulman, Kevin P. Weinfurt, for the HF-ACTION Investigators j

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.